Amdocs Limited
DOX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,150 | $1,144 | $1,128 | $1,110 |
| % Growth | 0.5% | 1.4% | 1.6% | – |
| Cost of Goods Sold | $720 | $711 | $698 | $682 |
| Gross Profit | $430 | $433 | $430 | $428 |
| % Margin | 37.4% | 37.9% | 38.1% | 38.5% |
| R&D Expenses | $88 | $87 | $82 | $84 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $122 | $128 | $135 | $122 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14 | $16 | $16 | $23 |
| Operating Expenses | $224 | $231 | $232 | $229 |
| Operating Income | $206 | $202 | $198 | $199 |
| % Margin | 17.9% | 17.7% | 17.5% | 17.9% |
| Other Income/Exp. Net | -$85 | -$12 | -$8 | -$6 |
| Pre-Tax Income | $121 | $191 | $189 | $192 |
| Tax Expense | $24 | $36 | $25 | $41 |
| Net Income | $97 | $154 | $163 | $151 |
| % Margin | 8.4% | 13.5% | 14.5% | 13.6% |
| EPS | 0.88 | 1.39 | 1.46 | 1.34 |
| % Growth | -36.7% | -4.8% | 9% | – |
| EPS Diluted | 0.88 | 1.39 | 1.45 | 1.33 |
| Weighted Avg Shares Out | 109 | 111 | 112 | 113 |
| Weighted Avg Shares Out Dil | 110 | 111 | 113 | 113 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $12 | $12 | $8 | $6 |
| Depreciation & Amortization | $53 | $50 | $46 | $46 |
| EBITDA | $186 | $252 | $244 | $245 |
| % Margin | 16.1% | 22% | 21.6% | 22.1% |